Cargando…

Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals

Fe(3)O(4)-Au hybrid nanoparticles (HNPs) have shown increasing potential for biomedical applications such as image guided stimuli responsive drug delivery. Incorporation of the unique properties of HNPs into thermally responsive scaffolds holds great potential for future biomedical applications. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Roach, Paul, McGarvey, David J., Lees, Martin R., Hoskins, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645763/
https://www.ncbi.nlm.nih.gov/pubmed/23603890
http://dx.doi.org/10.3390/ijms14048585
_version_ 1782268540506603520
author Roach, Paul
McGarvey, David J.
Lees, Martin R.
Hoskins, Clare
author_facet Roach, Paul
McGarvey, David J.
Lees, Martin R.
Hoskins, Clare
author_sort Roach, Paul
collection PubMed
description Fe(3)O(4)-Au hybrid nanoparticles (HNPs) have shown increasing potential for biomedical applications such as image guided stimuli responsive drug delivery. Incorporation of the unique properties of HNPs into thermally responsive scaffolds holds great potential for future biomedical applications. Here we successfully fabricated smart scaffolds based on thermo-responsive poly(N-isopropylacrylamide) (pNiPAM). Nanoparticles providing localized trigger of heating when irradiated with a short laser burst were found to give rise to remote control of bulk polymer shrinkage. Gold-coated iron oxide nanoparticles were synthesized using wet chemical precipitation methods followed by electrochemical coating. After subsequent functionalization of particles with allyl methyl sulfide, mercaptodecane, cysteamine and poly(ethylene glycol) thiol to enhance stability, detailed biological safety was determined using live/dead staining and cell membrane integrity studies through lactate dehydrogenase (LDH) quantification. The PEG coated HNPs did not show significant cytotoxic effect or adverse cellular response on exposure to 7F2 cells (p < 0.05) and were carried forward for scaffold incorporation. The pNiPAM-HNP composite scaffolds were investigated for their potential as thermally triggered systems using a Q-switched Nd:YAG laser. These studies show that incorporation of HNPs resulted in scaffold deformation after very short irradiation times (seconds) due to internal structural heating. Our data highlights the potential of these hybrid-scaffold constructs for exploitation in drug delivery, using methylene blue as a model drug being released during remote structural change of the scaffold.
format Online
Article
Text
id pubmed-3645763
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-36457632013-05-13 Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals Roach, Paul McGarvey, David J. Lees, Martin R. Hoskins, Clare Int J Mol Sci Article Fe(3)O(4)-Au hybrid nanoparticles (HNPs) have shown increasing potential for biomedical applications such as image guided stimuli responsive drug delivery. Incorporation of the unique properties of HNPs into thermally responsive scaffolds holds great potential for future biomedical applications. Here we successfully fabricated smart scaffolds based on thermo-responsive poly(N-isopropylacrylamide) (pNiPAM). Nanoparticles providing localized trigger of heating when irradiated with a short laser burst were found to give rise to remote control of bulk polymer shrinkage. Gold-coated iron oxide nanoparticles were synthesized using wet chemical precipitation methods followed by electrochemical coating. After subsequent functionalization of particles with allyl methyl sulfide, mercaptodecane, cysteamine and poly(ethylene glycol) thiol to enhance stability, detailed biological safety was determined using live/dead staining and cell membrane integrity studies through lactate dehydrogenase (LDH) quantification. The PEG coated HNPs did not show significant cytotoxic effect or adverse cellular response on exposure to 7F2 cells (p < 0.05) and were carried forward for scaffold incorporation. The pNiPAM-HNP composite scaffolds were investigated for their potential as thermally triggered systems using a Q-switched Nd:YAG laser. These studies show that incorporation of HNPs resulted in scaffold deformation after very short irradiation times (seconds) due to internal structural heating. Our data highlights the potential of these hybrid-scaffold constructs for exploitation in drug delivery, using methylene blue as a model drug being released during remote structural change of the scaffold. Molecular Diversity Preservation International (MDPI) 2013-04-19 /pmc/articles/PMC3645763/ /pubmed/23603890 http://dx.doi.org/10.3390/ijms14048585 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Roach, Paul
McGarvey, David J.
Lees, Martin R.
Hoskins, Clare
Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals
title Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals
title_full Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals
title_fullStr Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals
title_full_unstemmed Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals
title_short Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals
title_sort remotely triggered scaffolds for controlled release of pharmaceuticals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645763/
https://www.ncbi.nlm.nih.gov/pubmed/23603890
http://dx.doi.org/10.3390/ijms14048585
work_keys_str_mv AT roachpaul remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals
AT mcgarveydavidj remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals
AT leesmartinr remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals
AT hoskinsclare remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals